Expertise in
4
conditions

Pieter Gillard

Leuven, VLG, BE 
Expertise in
4
conditions
Leuven, VLG, BE 
OverviewLocationsClinical Research

Overview

Pieter Gillard practices in Leuven, Belgium. Mr. Gillard is highly rated in 4 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Agenesis of the Dorsal Pancreas, Islet Cell Transplantation, and Kidney Transplant.

His clinical research consists of co-authoring 104 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Leuven, VLG, Belgium
Other Locations
Brussels, BRU, Belgium
29, Rue Du Parc, Verviers, WAL 4800, Belgium
Belgium
Boulevard Du XII De Ligne, Liege, WAL 4000, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The Impact of Hybrid Closed-loop Insulin Delivery (Medtronic MiniMed 670G and 780G System, and Tandem t:Slim X2 Control-IQ) on Glycemic Control and Patient-reported Outcomes in People Living With Type 1 Diabetes: a Multicenter Real-world Observational Study in Belgium
The Impact of Hybrid Closed-loop Insulin Delivery (Medtronic MiniMed 670G and 780G System, and Tandem t:Slim X2 Control-IQ) on Glycemic Control and Patient-reported Outcomes in People Living With Type 1 Diabetes: a Multicenter Real-world Observational Study in Belgium
Enrollment Status: Active_not_recruiting
Publish Date: March 17, 2025
Intervention Type: Device
A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 400 mg Twice a Day Oral Ladarixin in Patients With New-onset Type 1 Diabetes
A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 400 mg Twice a Day Oral Ladarixin in Patients With New-onset Type 1 Diabetes
Enrollment Status: Completed
Publish Date: April 19, 2024
Intervention Type: Drug
Study Phase: Phase 2
The Impact of Flash Glucose Monitoring on Clinical Outcome Parameters in Diabetes Patients
The Impact of Flash Glucose Monitoring on Clinical Outcome Parameters in Diabetes Patients
Enrollment Status: Completed
Publish Date: October 20, 2020
Evaluation of the Accuracy and Precision of Flash Glucose Monitoring Sensors in Different Sites: the Abdomen and Upper Thigh Compared to the Upper Arm
Evaluation of the Accuracy and Precision of Flash Glucose Monitoring Sensors in Different Sites: the Abdomen and Upper Thigh Compared to the Upper Arm
Enrollment Status: Completed
Publish Date: August 07, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

104 Total Publications

The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.
Journal: Journal of diabetes science and technology
Published: May 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gillard's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile